Moderna’s 177% Surge: 3 US Stocks Poised for Similar Short-Squeeze Breakouts
Moderna's 177% surge on positive trial data and short covering reveals a pattern of high short interest plus a binary catalyst. Three US biotech stocks—BioNTech, Iovance, and Caribou—currently show similar...



